Stimcell Energetics (STME) Property, Plant & Equipment (Net) Growth (1y) (2017 - 2022)
Stimcell Energetics (STME) Property, Plant & Equipment (Net) Growth (1y) (2017 - 2022) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.81 Bn | 193.21 Bn | 7.27 Bn | 12.44% |
| 2 | Stryker | 127.76 Bn | 124.28 Bn | 4.50 Bn | 6.92% |
| 3 | Medtronic | 118.77 Bn | 109.55 Bn | 6.41 Bn | 8.48% |
| 4 | Boston Scientific | 73.25 Bn | 72.71 Bn | 3.85 Bn | 19.21% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 6.67% |
| 6 | Dexcom | 34.43 Bn | 32.49 Bn | 830.00 Mn | 8.23% |
| 7 | GE HealthCare Technologies | 33.88 Bn | 31.77 Bn | 2.18 Bn | 6.21% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -1.40% |
| 9 | Steris | 23.11 Bn | 22.63 Bn | 684.20 Mn | 5.69% |
| 10 | Stimcell Energetics | 4.65 Mn | 4.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2022 | -87.70% |
| Nov 30, 2021 | -81.20% |
| Aug 31, 2021 | -77.89% |
| May 31, 2021 | -34.91% |
| Feb 28, 2021 | -30.25% |
| Nov 30, 2020 | -27.70% |
| Aug 31, 2020 | -20.99% |
| May 31, 2020 | 43.33% |
| Feb 29, 2020 | 65.17% |
| Nov 30, 2019 | 66.87% |
| Feb 28, 2019 | -98.16% |
| Nov 30, 2018 | -98.47% |
| Feb 28, 2018 | -69.32% |
| May 31, 2017 | -6.52% |